Related Experiment Video
Updated: Feb 24, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
13.6K
Selective lymph node dissection in early-stage non-small cell lung cancer
Han Han1,2, Haiquan Chen1,2
1Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Journal of Thoracic Disease
|August 26, 2017
Summary
Selective lymph node dissection (SLND) is crucial for early-stage non-small cell lung cancer (NSCLC) to minimize surgical trauma. Understanding lobe-specific lymph node drainage patterns guides precise metastasis removal while preserving healthy nodes.
Area of Science:
- Surgical Oncology
- Thoracic Surgery
- Cancer Research
Background:
- Lymph node dissection is essential for early-stage non-small cell lung cancer (NSCLC) treatment.
- Balancing metastatic lymph node removal with preserving intact nodes is critical.
- Current approaches may cause unnecessary surgical trauma in early-stage NSCLC patients.
Purpose of the Study:
- To review lobe-specific lymph node drainage patterns in NSCLC.
- To provide guidance for selective lymph node dissection (SLND) in early-stage NSCLC.
- To inspire further research and clinical trials in SLND.
Main Methods:
- Literature review of existing findings on lobe-specific lymph node drainage.
- Compilation of information on histologic views and tumor markers relevant to SLND.
- Analysis of current protocols for SLND.
Main Results:
- Established lobe-specific lymph node drainage patterns are key for effective SLND.
- Minimally invasive SLND offers clinical benefits by reducing surgical trauma.
- Histologic views and tumor markers can aid in SLND decision-making.
Conclusions:
- SLND, guided by lobe-specific drainage patterns, is a preferred approach for early-stage NSCLC.
- This strategy aims to optimize oncologic outcomes while minimizing patient morbidity.
- Further research is encouraged to refine SLND techniques and protocols.